Skip to content

Role of homoeopathic medicines in the treatment of urolithiasis

Usefulness Of ‘Kidney Calculi’ As An Eliminating Rubric From Boger Boenninghausen’s Characteristics Repertory In The Management Of Urolithiasis- A Prospective Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065294
Enrollment
31
Registered
2024-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N20- Calculus of kidney and ureter Health Condition 2: N21- Calculus of lower urinary tract

Interventions

Intervention1: Homoeopathic medicine: 15 months study 6 months enrollment 6 months follow up 3 months analysis oral route of administration pill form 30 pill size first dose after taking the case subs

Sponsors

Principal Bakson Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Participants of age group 19-59 years of both genders 2 Size of calculi 5mm-7mm 3 Cases (symptomatic/ asymptomatic) with radiological evidence X-ray/USG(KUB)of calculi in kidney/ureter/bladder 4 Participants giving consent to participate in the study

Exclusion criteria

Exclusion criteria: 1 Participants with moderate/severe hydronephrosis 2 Participants unwilling to participate in the study or not to undergo any investigation, if advised 3 Pregnant and lactating females 4 Participants who are bedridden or have structural kidney defect 5 Cases having staghorn calculus

Design outcomes

Primary

MeasureTime frame
It is expected to have positive changes on USS scaleTimepoint: 15 months study 6 months enrollment 6 months follow up 3 months data analysis USS scale to be used at baseline, 12 weeks and 24 weeks.

Secondary

MeasureTime frame
It is expected to have positive changes in USGTimepoint: 15 months study 6 months enrollment 6 months follow up 3 months data analysis USG will be done at baseline and at the end of 24 weeks

Countries

India

Contacts

Public ContactDr Aditi Goyal

Bakson Homoeopathic Medical College and Hospital

rupalsingh1999@gmail.com7982854958

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026